Cited by 373Sperm and Testicular FunctionMale Reproductive Health StudiesReproductive Health and Technologies

Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I

Open access
Schlegel, Peter N., Sigman, Mark, Collura, Barbara, De Jonge, Christopher J., Eisenberg, Michael L., Lamb, Dolores J., Mulhall, John P., Niederberger, Craig +7 more·2021·Fertility and Sterility

Abstract

Purpose The summary presented herein represents Part I of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Part I outlines the appropriate evaluation of the male in an infertile couple. Recommendations proceed from obtaining an appropriate history and physical exam (Appendix I), as well as diagnostic testing, where indicated. Materials/methods The Emergency Care Research Institute Evidence-based Practice Center team searched PubMed®, Embase®, and Medline from January, 2000 through May, 2019. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions. (Table 1) This summary is being simultaneously published in Fertility and Sterility and The Journal of Urology. Results This Guideline provides updated, evidence-based recommendations regarding evaluation of male infertility as well as the association of male infertility with other important health conditions. The detection of male infertility increases the risk of subsequent development of health problems for men. In addition, specific medical conditions are associated with some causes for male infertility. Evaluation and treatment recommendations are summarized in the associated algorithm. (Figure 1) CONCLUSION: The presence of male infertility is crucial to the health of patients and its effects must be considered for the welfare of society. This document will undergo updating as the knowledge regarding current treatments and future treatment options continues to expand.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2020.11.015

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Semen analysis is the most basic evaluation of male infertility, and evaluation of semen parameters is currently based on the standards defined in the WHO laboratory manual for the examination and processing of human semen.

    “Semen analysis (SA) represents the most basic evaluation of male infertility. The evaluation of semen parameters is currently based on the standards defined in the laboratory manual for the examination and processing of human semen created by the World Health Organization (WHO) [8,9,10].”

    From The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis (2021) · cites this paper as [10]

    The guideline’s section on initial infertility evaluation recommends one or more semen analyses and calls semen analysis an important component of the initial male evaluation. That supports its role as a basic evaluation, but the passages from our copy do not say that semen parameters are evaluated according to standards in the WHO laboratory manual. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 18

  1. The optimal evaluation of the infertile male: Aua best practice state- ment, 2010. Practice committee of the american society for reproductive medicine. Diagnostic evaluation of the infertile male: A committee opinion. Fertil Steril 2012;98:294.
  2. Honig SC, Lipshultz LI, Jarow J. Significant medical pathology uncovered by a comprehensive male infertility evaluation. Fertil Steril 1994;62:1028.
  3. Kolettis PN, Sabanegh ES. Significant medical pathology discovered during a male infertility evaluation. J Urol 2001;166:178.
  4. Bach PV, Patel N, Najari BB, et al. Changes in practice patterns in male infer- tility cases in the united states: The trend toward subspecialization. Fertil Steril 2018;110:76.
  5. Salonia A, Matloob R, Gallina A, et al. Are infertile men less healthy than fertile men? Results of a prospective case-control survey. Eur Urol 2009; 56:1025.
  6. Hanson HA, Anderson RE, Aston KI, et al. Subfertility increases risk of testic- ular cancer: Evidence from population-based semen samples. Fertil Steril 2016;105:322.
  7. Mancini M, Carmignani L, Gazzano G, et al. High prevalence of testicular cancer in azoospermic men without spermatogenesis. Hum Reprod 2007; 22:1042.
  8. Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 2005; 174:1819.
  9. Eisenberg ML, Betts P, Herder D, et al. Increased risk of cancer among azoo- spermic men. Fertil Steril 2013;100:681.
  10. Glazer CH, Bonde JP, Eisenberg ML, et al. Male infertility and risk of nonma- lignant chronic diseases: A systematic review of the epidemiological evi- dence. Semin Reprod Med 2017;35:282.
  11. Guzick DS, Overstreet JW. Factor-Litvak P et al: Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001;345:1388.
  12. Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995; 332:1475.
  13. Yu J, Chen Z, Ni Y, et al. Cftr mutations in men with congenital bilateral absence of the vas deferens (cbavd): A systemic review and meta-analysis. Hum Reprod 2012;27:25.
  14. Mak V, Zielenski J, Tsui LC, et al. Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. Jama 1999;281:2217.
  15. Elmer DeWitt M, Greene DJ, Gill B, et al. Isolated right varicocele and inci- dence of associated cancer. Urology 2018;117:82.
  16. Kolettis PN, Sandlow JI. Clinical and genetic features of patients with congenital unilateral absence of the vas deferens. Urology 2002;60:1073.
  17. Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 1996;155:1644.
  18. Weiske WH, Salzler N, Schroeder-Printzen I, et al. Clinical findings in congenital absence of the vasa deferentia. Andrologia 2000;32:13. Diagn ostico y tratamiento de la infertilidad masculina: guía de la AUA/ ASRM parte 1. Objetivo: El resumen representa la Parte I de una serie de dos partes dedicada al diagn ostico y tratamiento de la infertilidad masculina: Guía de la AUA/ASRM. La primera parte describe la evaluaci on apropiada del hombre en una pareja inf ertil. Las recomendaciones pasan la realizaci on de una historia y un examen físico apropiados (Ap endice I), así como pruebas de diagn ostico, cuando est e resulte indicado. Materiales/M etodos: El equipo del Centro de Pr actica Basada en la Evidencia del Instituto de Investigaci on de Cuidados de Emergencia busc o en PubMed, Embase y Medline desde enero de 2000 hasta mayo de 2019. Cuando existían pruebas suficientes, se asignaba al conjunto de pruebas una calificaci on de A (alta), B (moderada) o C (baja) para el apoyo de las recomendaciones fuertes, moderadas o condicionales. En ausencia de pruebas suficientes, se proporciona informaci on adicional en forma de Principios Clínicos y Opiniones de Expertos. (Cuadro 1). Este resumen se publica simult aneamente en Fertility and Sterility y The Journal of Urology. Resultados: Esta guía proporciona recomendaciones actualizadas y basadas en la evidencia sobre la evaluaci on de la infertilidad mas- culina, así como la asociaci on de la infertilidad masculina con otras condiciones de salud importantes. La detecci on de la infertilidad masculina aumenta el riesgo de posterior desarrollo de los problemas de salud de los hombres. Adem as, determinadas afecciones m edicas se asocian con algunas causas de la infertilidad masculina. La evaluaci on y las recomendaciones de tratamiento se resumen en el algoritmo asociado. (Figura 1) on: La presencia de la infertilidad masculina es crucial para la salud de los pacientes y sus efectos deben ser considerados para bienestar de sociedad. Este documento se actualizar a a medida que contin el conocimiento sobre los tratamientos actuales y las opciones de tratamiento futuras para expandirse.

Cited by

Sorted by citations

Authors
Schlegel, P. N., Sigman, M., Collura, B., De Jonge, C. J., Eisenberg, M. L., Lamb, D. J., Mulhall, J. P., Niederberger, C., Sandlow, J. I., Sokol, R. Z., Spandorfer, S. D., Tanrikut, C., Treadwell, J. R., Oristaglio, J. T., & Zini, A.
Affiliations
  • NewYork–Presbyterian Hospital (US)
  • Brown University (US)
  • ReSoLVE Center of Excellence (FI)
  • Stanford Medicine (US)
  • Weill Cornell Medicine (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Cornell University (US)
  • Medical College of Wisconsin (US)
  • University of Southern California (US)
  • Georgetown University (US)
  • ECRI Institute (US)
  • McGill University (CA)
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2021-01
Volume
115
Issue
1
Pages
54-61
ISSN
0015-0282 (ISSN-L)
OpenAlex
W3111127730
Cited by
373
References
1
Citations by year
2026: 58 · 2025: 51 · 2024: 69 · 2023: 79 · 2022: 71 · 2021: 44 · 2019: 1
FWCI
42.83
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Gilead Sciences
  • National Institutes of Health
  • EMD Serono
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Health Professions › General Health Professions › Male Reproductive Health Studies
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
male infertility, infertility evaluation, infertility diagnosis, infertility treatment, infertile couples, diagnostic testing, clinical guidelines
MeSH terms
Adult, Endocrinology, Female, Humans, Infertility, Male, Male, Pregnancy, Societies, Medical, Urology, Reproductive Medicine, Evidence-Based Practice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review